Dendrite International, Inc. v. Doe No. 3

Raman spectroscopy market to grow by USD 287.28 million from 2022 to 2027 | The rising focus on drug discovery and development to boost market growth- Technavio

Retrieved on: 
Friday, October 13, 2023

The potential growth difference for the Raman spectroscopy market between 2022 and 2027 is USD 287.28 million.

Key Points: 
  • The potential growth difference for the Raman spectroscopy market between 2022 and 2027 is USD 287.28 million.
  • Buy the full report here
    The rising focus on drug discovery and development is the key factor driving market growth.
  • Thus, the increase in drug discovery and development will drive the demand for Raman spectroscopy, which will boost the growth of the market during the forecast period.
  • The global atomic spectroscopy market size is estimated to grow by USD 2,214.33 million at a CAGR of 7.02% between 2022 and 2027.

Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion

Retrieved on: 
Monday, May 8, 2023

Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.
  • Under the terms of the definitive agreement, Baxter will receive $4.25 billion in cash, subject to certain closing adjustments, with net after-tax proceeds currently estimated to be approximately $3.4 billion.
  • Baxter intends to utilize the after-tax proceeds to reduce its debt, consistent with the company’s stated capital allocation priorities.
  • Advent International and Warburg Pincus have extensive experience helping innovative healthcare companies advance their mission and strategic priorities.

Pharmaceutical Traceability Market size to grow by USD 9.37 billion from 2021 to 2026, Driven by the growing concerns over counterfeit drugs - Technavio

Retrieved on: 
Wednesday, April 5, 2023

NEW YORK, April 5, 2023 /PRNewswire/ -- The global pharmaceutical traceability market size is estimated to increase by USD 9.37 billion from 2021 to 2026.

Key Points: 
  • NEW YORK, April 5, 2023 /PRNewswire/ -- The global pharmaceutical traceability market size is estimated to increase by USD 9.37 billion from 2021 to 2026.
  • One of the key factors fueling the growth in the pharmaceutical traceability market is the growing concerns over counterfeit drugs.
  • Hence, growth in the availability of counterfeit drugs has increased the demand for anti-counterfeiting technologies that utilize various traceability systems.
  • By geography, the global pharmaceutical traceability market is segmented into North America, Europe, Asia, and Rest of World (ROW).

CACI Announces $250 Million Accelerated Share Repurchase Agreement

Retrieved on: 
Monday, January 30, 2023

CACI International Inc ( NYSE: CACI ), a leading provider of expertise and technology to government enterprise and mission customers, announced today that it has entered into an accelerated share repurchase agreement (ASR) to repurchase $250 million of common stock under its previously announced $750 million share repurchase authorization.

Key Points: 
  • CACI International Inc ( NYSE: CACI ), a leading provider of expertise and technology to government enterprise and mission customers, announced today that it has entered into an accelerated share repurchase agreement (ASR) to repurchase $250 million of common stock under its previously announced $750 million share repurchase authorization.
  • This equates to approximately 845,000 shares at the closing price on January 27, 2023, representing approximately 3.6% of CACI’s outstanding common stock.
  • Given the execution of this repurchase agreement, CACI now expects fiscal year 2023 interest expense to be between $80 and $85 million and the diluted weighted average share count to be approximately 23.5 million.
  • Given the timing of the ASR in our fiscal year, we are reiterating our prior adjusted net income and adjusted earnings per share guidance.

Global Chronic Obstructive Pulmonary Disease Drugs Market to Grow by $66.54 Billion During 2023-2027 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023

This study identifies the expanding research in curative approaches as one of the prime reasons driving the chronic obstructive pulmonary disease drugs market growth during the next few years.

Key Points: 
  • This study identifies the expanding research in curative approaches as one of the prime reasons driving the chronic obstructive pulmonary disease drugs market growth during the next few years.
  • Also, advances in drug delivery devices and the growing use of e-cigarettes and other products for people to quit smoking will lead to sizable demand in the market.
  • The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
  • The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Coloured Ties Capital Provides Lithium Portfolio Update and Substantial Issuer Bid Tender Deadline Update

Retrieved on: 
Tuesday, January 10, 2023

Vancouver, British Columbia--(Newsfile Corp. - January 10, 2023) -  Coloured Ties Capital Inc. (TSXV: TIE) ("CTI" or the "Company") is pleased to provide the following update on the Company's lithium portfolio.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - January 10, 2023) -  Coloured Ties Capital Inc. (TSXV: TIE) ("CTI" or the "Company") is pleased to provide the following update on the Company's lithium portfolio.
  • The claims are immediately adjacent to claims currently held by Winsome Resources and Vision Lithium Inc., a TSXV listed Lithium explorer.
  • Hertz Lithium Inc. ("Hertz Lithium") - The Company currently holds 3,000,000 common shares of Hertz Lithium.
  • Shareholders who wish to tender their shares are urged to tender their shares in advance of the deadline to ensure efficient processing time.

FINEQIA CLOSES FINAL TRANCHE OF PRIVATE PLACEMENT FOR TOTAL $5.3 MLN

Retrieved on: 
Thursday, December 15, 2022

VANCOUVER, BC, Dec. 15, 2022 /PRNewswire/ -Fineqia International Inc. (the "Company" or "Fineqia") (CSE: FNQ) (OTC: FNQQF) (Frankfurt: FNQA) announces the closing of its non-brokered private placement ("Offering") via its fourth and final tranche.

Key Points: 
  • VANCOUVER, BC, Dec. 15, 2022 /PRNewswire/ -Fineqia International Inc. (the "Company" or "Fineqia") (CSE: FNQ) (OTC: FNQQF) (Frankfurt: FNQA) announces the closing of its non-brokered private placement ("Offering") via its fourth and final tranche.
  • The Company issued 482,460,590units (the "Units") to raise gross proceeds of $4,824,605.90 in total in the private placement, along with a conversion of debt of $506,975 and payment of finder's fees worth $19,177.20.
  • The Company had raised the ceiling of its private placement to $5 million from $4 million on Oct 12, 2022, to accommodate increased investor interest.
  • "Having the right people on our side helps pave the way for growth
    The fourth and final tranche comprised a total of $353,500 including gross proceeds of $68,500 and conversion of external debt of C$285,000.

Swedish Match AB applies for delisting

Retrieved on: 
Monday, December 5, 2022

STOCKHOLM, Dec. 5, 2022 /PRNewswire/ --Philip Morris Holland Holdings B.V. ("PMHH"), an affiliate of Philip Morris International Inc., declared the public offer for Swedish Match AB ("Swedish Match" or the "Company") unconditional on November 7, 2022.

Key Points: 
  • STOCKHOLM, Dec. 5, 2022 /PRNewswire/ --Philip Morris Holland Holdings B.V. ("PMHH"), an affiliate of Philip Morris International Inc., declared the public offer for Swedish Match AB ("Swedish Match" or the "Company") unconditional on November 7, 2022.
  • PMHH controls more than 90 percent of the shares in Swedish Match and has initiated squeeze-out proceedings in respect of the remaining shares in the Company.
  • The Board of Swedish Match has today resolved to apply for delisting of the Company's shares from Nasdaq Stockholm.
  • The last day of trading in the Company's shares on Nasdaq Stockholm will be announced as soon as the Company has received confirmation from Nasdaq Stockholm.

VICI Properties Inc. Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Friday, November 4, 2022

VICI Properties Inc. (NYSE: VICI) (VICI Properties or the Company), an experiential asset real estate investment trust, today announced the pricing of an underwritten public offering of 16,500,000 shares of its common stock subject to the forward sale agreements described below, which will result in approximately $509.9 million of gross proceeds (assuming such forward sale agreements are physically settled) before any offering expenses.

Key Points: 
  • VICI Properties Inc. (NYSE: VICI) (VICI Properties or the Company), an experiential asset real estate investment trust, today announced the pricing of an underwritten public offering of 16,500,000 shares of its common stock subject to the forward sale agreements described below, which will result in approximately $509.9 million of gross proceeds (assuming such forward sale agreements are physically settled) before any offering expenses.
  • (or their respective affiliates) (the forward purchasers) with respect to the shares of common stock covered by the offering.
  • The Company will not initially receive any proceeds from the sale of shares of common stock by the forward purchasers or their respective affiliates.
  • VICI Properties also owns four championship golf courses and 34 acres of undeveloped or underdeveloped land adjacent to the Las Vegas Strip.

VICI Properties Inc. Announces Public Offering of Common Stock

Retrieved on: 
Thursday, November 3, 2022

VICI Properties Inc. (NYSE: VICI) (VICI Properties or the Company), an experiential asset real estate investment trust, today announced it has commenced an underwritten public offering of 16,500,000 shares of its common stock, all of which are expected to be offered on a forward basis through the forward purchasers or their respective affiliates in connection with the forward sale agreements described below.

Key Points: 
  • VICI Properties Inc. (NYSE: VICI) (VICI Properties or the Company), an experiential asset real estate investment trust, today announced it has commenced an underwritten public offering of 16,500,000 shares of its common stock, all of which are expected to be offered on a forward basis through the forward purchasers or their respective affiliates in connection with the forward sale agreements described below.
  • The underwriters of the offering also expect to be granted a 30-day option to purchase up to 2,475,000 additional shares of the Companys common stock.
  • (or their respective affiliates) (the forward purchasers) with respect to the shares of common stock covered by the offering.
  • VICI Properties also owns four championship golf courses and 34 acres of undeveloped or underdeveloped land adjacent to the Las Vegas Strip.